Close

Analyst Ratings for Bristol-Myers Squibb Co. (BMY) [Sells]

BMY Rating Summary

BMY Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BMY
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $77.86 (+3.6%) * Over Last 12-Mos
Rating Score: 4.2 / 10   Percentile Rank: 39%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/2/2022 CFRA N/A Downgrade Sell
(Hold)
66.00
(N/A)
77.20
(75.14)
-2.67% Details
4/6/2022 Morgan Stanley
» Updated 5/2/2022
Matthew Harrison Downgrade Underweight
(Equalweight)
63.00
(64.00)
73.79
(75.14)
1.83% Details
Like BMY Ratings? Also take a look at CELG, TPTX, NKTR, IMTX

BMY Ratings News